| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/05/2010 | EP2181715A1 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/05/2010 | EP2181709A1 Synergic combination of analgesic compounds |
| 05/05/2010 | EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
| 05/05/2010 | EP1414486B1 Use of glp-2 in combination with another therapeutic agent in bone-related disorders |
| 05/05/2010 | EP1274414B1 Nasal administration of metoclopramide for the treatment of gastroparesis |
| 05/05/2010 | EP1227803B1 compounds for inhibiting iapp-associated amyloid deposits |
| 05/05/2010 | EP0946185B2 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND |
| 05/05/2010 | CN1943771B The pharmaceutical composition with actions on the NEI network and application thereof |
| 05/05/2010 | CN1923282B Anti-cancer slow release injection comprising hormone drug |
| 05/05/2010 | CN1923281B Anti-cancer slow release injection comprising plant alkaloid |
| 05/05/2010 | CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease |
| 05/05/2010 | CN1809353B Medicine for prevention of and treatment for arteriosclerosis and hypertension. |
| 05/05/2010 | CN1787820B Composition for improving cognition and memory |
| 05/05/2010 | CN1761450B Skin preparation for external use characterized by containing sugar derivative of a,a-trehalose |
| 05/05/2010 | CN1744917B Sustained-release pharmaceutical composition for lung administration |
| 05/05/2010 | CN1726037B Treatment of headache with antipsychotics delivered by inhalation |
| 05/05/2010 | CN1657100B Nano-class preparation for selective target stomach cancer-and lymph system and its preparation method |
| 05/05/2010 | CN1653454B Method of forming molecule function network |
| 05/05/2010 | CN1649569B Controlled release dosage forms |
| 05/05/2010 | CN1642574B Remedies for glomerular diseases |
| 05/05/2010 | CN1630526B Systems and methods for treating patients with processed lipoaspirate cells |
| 05/05/2010 | CN1568978B Composition for preventing and treating whelk |
| 05/05/2010 | CN1511036B Combination comprising signal transduction inhibitor and epothilone derivative |
| 05/05/2010 | CN1446261B Modified cytokines for use in cancer therapy |
| 05/05/2010 | CN101702884A Therapy for hyperglycemia, related disorders and erectile dysfunction |
| 05/05/2010 | CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases |
| 05/05/2010 | CN101700401A Polyalkylene glycol with moiety for conjugating biologicallyactive compound |
| 05/05/2010 | CN101700247A Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
| 05/05/2010 | CN101700235A Self-assembling compound film-controlled slow-release preparation and preparation method thereof |
| 05/05/2010 | CN101023119B Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
| 05/04/2010 | US7709529 Treatment of cancer with glutamine |
| 05/04/2010 | US7709462 Implantable and biocompatible gellable composition |
| 05/04/2010 | US7709459 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 05/04/2010 | US7709455 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist |
| 05/04/2010 | US7709451 Method and composition for treating immune complex associated disorders |
| 05/04/2010 | US7709442 In vivo synthesis of connective tissues |
| 05/04/2010 | US7709020 Implantable device comprising phosphorus-containing macrolides |
| 05/04/2010 | US7709010 Papillomavirus vaccine compositions |
| 05/04/2010 | US7709002 Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes |
| 05/04/2010 | US7708989 Administering nitrosated angiotensin converting enzyme inhibitors and other nitrosated compounds for cardiovascular disorders and treatment of hypertensive agents |
| 05/04/2010 | US7708988 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria; reducing gastrointestinal colonization by a pathogenic Clostridium bacterium |
| 05/04/2010 | US7708987 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents |
| 05/04/2010 | US7707970 immunogens |
| 05/04/2010 | CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators |
| 05/04/2010 | CA2455566C (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 05/04/2010 | CA2453609C Bridged piperidine derivatives as melanocortin receptor agonists |
| 05/04/2010 | CA2448863C Increased and sustained in vivo gene expression using a nucleic acid, histone, and amphipathic compound composition |
| 05/04/2010 | CA2431519C Topical composition and method for treating urinary stress incontinence |
| 05/04/2010 | CA2417646C Topical gel delivery system |
| 05/04/2010 | CA2406202C Whitening compositions containing ascomycete derived enzyme |
| 05/04/2010 | CA2378438C Methods for preparation of lipid-encapsulated therapeutic agents |
| 05/04/2010 | CA2352484C Pressurised metered dose inhalers (mdi) |
| 05/04/2010 | CA2335364C Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 05/04/2010 | CA2281920C Compositions and methods for modulating cellular nf-.kappa.b activation |
| 05/04/2010 | CA2158134C Supplemented tissue sealant |
| 04/29/2010 | WO2010048423A1 Levetiracetam immunoassays |
| 04/29/2010 | WO2010047999A2 Method for treating pulmonary arterial hypertension |
| 04/29/2010 | WO2010047453A1 Pharmaceutical composition comprising cilnidipine and telmisartan |
| 04/29/2010 | WO2010047452A1 Pharmaceutical composition comprising lercanidipine and telmisartan |
| 04/29/2010 | WO2009131553A3 Methods of altering bone growth by administration of sost or wise antagonist or agonist |
| 04/29/2010 | WO2009117277A3 Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
| 04/29/2010 | WO2008146911A9 Antibody directed against il13ra2, and diagnostic/therapeutic agent comprising the antibody |
| 04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
| 04/29/2010 | US20100105767 Compounds, compositions and methods |
| 04/29/2010 | US20100105715 Polymer conjugates of opioid antagonists |
| 04/29/2010 | US20100105701 Gyrase inhibitors and uses thereof |
| 04/29/2010 | US20100105683 Compounds useful for inhibiting chk1 |
| 04/29/2010 | US20100105632 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 04/29/2010 | US20100105603 Methods and Preparations For Curing Clinically Ill Patients |
| 04/29/2010 | US20100105122 Oncolytic Viruses as Phenotyping Agents for Neoplasms |
| 04/29/2010 | US20100105121 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/29/2010 | US20100104632 Drug Having Regulatory Cell Ligand Contained in Liposome |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104556 Epitope-tag for surface-expressed proteins and uses thereof |
| 04/29/2010 | US20100104545 Nutritional Composition To Promote Healthy Development And Growth |
| 04/29/2010 | US20100104543 Cellular compositions and methods of making and using them |
| 04/29/2010 | US20100104535 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 04/29/2010 | DE102008053776A1 Active agent combination, useful e.g. in alcohol conserved or alcohol-free tattoo inks and tattoo inks with organic azo pigments, comprises water, vitamin, which is converted into pantothenic acid, and skin moisture-regulating substances |
| 04/29/2010 | DE102008053048A1 Medicament, useful e.g. for treating diabetes, controlling fasting, postprandial or postabsorptive blood glucose concentration in diabetic patients and improving glucose tolerance, comprises insulin and glucagon-like peptide-1 agonist |
| 04/29/2010 | CA2739489A1 Method for treating pulmonary arterial hypertension |
| 04/28/2010 | EP2179745A1 Combinations comprising epothilones and pharmaceutical uses thereof |
| 04/28/2010 | EP2179741A1 Methods for treatment of headaches by administraton of oxytocin |
| 04/28/2010 | EP2179737A2 Modulating responsiveness to steroids |
| 04/28/2010 | EP2179732A1 Pharmaceutical composition combining an enzyme hmg-coa reductase inhibiting agent and a gastrointestinal lipase enzyme inhibiting agent |
| 04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 04/28/2010 | EP2179724A2 Tamper-resistant products for opioid delivery |
| 04/28/2010 | EP2178915A2 Anti cd37 antibodies |
| 04/28/2010 | EP2178563A2 Combination anti-cancer therapy comprising an inhibitor of both mtorc1 and mtorc2 |
| 04/28/2010 | EP2178562A1 Synergistic combinations of vr-1 antagonists and cox-2 inhibitors |
| 04/28/2010 | EP1572173B1 Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 04/28/2010 | EP1546362B1 Apolipoprotein e stable folding intermediate and methods of use thereof |
| 04/28/2010 | EP1480615B1 Formoterol superfine formulation |
| 04/28/2010 | EP1472225B1 2-piperazine-pyridines useful for treating pain |
| 04/28/2010 | EP1356067B1 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs |
| 04/28/2010 | EP1347751B1 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 04/28/2010 | EP1295607B1 Antitumor effect potentiators |
| 04/28/2010 | EP1259606B1 Compositions useful for regulating parkin gene activity |
| 04/28/2010 | EP0831858B1 Intrauterine chemical necrosing method and composition |
| 04/28/2010 | CN1956732B Antimycobacterial pharmaceutical composition comprising an antitubercular drug |
| 04/28/2010 | CN1902352B Allergen suppressor, allergen-suppression processed fiber and method of producing the same |